Skip to main content

UPDATE 3-Biogen's Spinraza drives third-quarter profit beat

* MS drug Tecfidera misses analyst estimates (Adds CEO, analyst comment, share movement, Spinraza details from conference call)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.